Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Zwischen Gesundheit und Wirtschaft: Normen und Interessenkonflikte in der behördlichen Arzneimittelregulierung im Deutschen Reich 1871–1945

Zwischen Gesundheit und Wirtschaft: Normen und Interessenkonflikte in der behördlichen... AbstractThe article deals with the question of why the German authorities failed to reform drug regulation between 1871 and 1945, although it was urgently required due to the fundamental pharmaceutical change. The German drug regulation was initially dominated by non-state actors. The state was faced with numerous and powerful actors who represented completely different interests and standards, especially in health and economic policy. On the one hand, the reform of pharmaceutical law was blocked because the authorities were unable to balance these multiple normativities. On the other hand, the reform was complicated by external, non-medical norms and constraints. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Administory de Gruyter

Zwischen Gesundheit und Wirtschaft: Normen und Interessenkonflikte in der behördlichen Arzneimittelregulierung im Deutschen Reich 1871–1945

Lenhard-Schramm, Niklas
Administory , Volume 5 (1): 20 – Dec 1, 2020
Download PDF
20 pages

Loading next page...
 
/lp/de-gruyter/zwischen-gesundheit-und-wirtschaft-normen-und-interessenkonflikte-in-m0RtDR1NWE

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
de Gruyter
Copyright
© 2021 Niklas Lenhard-Schramm, published by Sciendo
eISSN
2519-1187
DOI
10.2478/adhi-2020-0008
Publisher site
See Article on Publisher Site

Abstract

AbstractThe article deals with the question of why the German authorities failed to reform drug regulation between 1871 and 1945, although it was urgently required due to the fundamental pharmaceutical change. The German drug regulation was initially dominated by non-state actors. The state was faced with numerous and powerful actors who represented completely different interests and standards, especially in health and economic policy. On the one hand, the reform of pharmaceutical law was blocked because the authorities were unable to balance these multiple normativities. On the other hand, the reform was complicated by external, non-medical norms and constraints.

Journal

Administory – de Gruyter

Published: Dec 1, 2020

There are no references for this article.